270 articles
Keith Boettiger, President, Abbott Neuromodulation discusses the company's new Patient Controller app that is being integrated into their broader Neur...
Adam Bingaman, Director of Abdominal Organ Transplantation at Methodist Hospital/Specialty and Transplant in San Antonio, TX discusses tips for transpla...
Jim Doherty, CRO at Sage Therapeutics discuss the three clinical trials, one major depressive disorder (MDD), one postpartum depression (PPD) and one Es...
Aidan Foley, CEO at True Digital Surgery discusses the partnership with Aesculap, Inc., and the Aesculap Aeos® Robotic Digital Surgical Microscope that...
Mei Mei Hu, JD, co-founder and co-CEO and Peter Diamandis, MD, co-founder and vice chairman at COVAXX, a division of United Biomedical, discuss UB-612, ...
Rahul Aras, CEO of Iterion Therapeutics, a clinical stage biotechnology company developing novel cancer therapeutics discusses the company's lead produc...
Spiro Rombotis, President and CEO of Cyclacel Pharmaceuticals, a developer of novel therapies that target various phases of cell cycle control for the t...
Josefa Briceno, M.D., Medical Head for the DNA Damage Response Franchise in US Medical Affairs at AstraZeneca discusses the recent FDA approval of LYNPA...
Geoffrey Eubank, M.D., Medical Director of the Mid Ohio MS Center at OhioHealth Neurological Physicians, discusses 2 Phase lll clinical trials of Enspry...
Kathleen Hawker, M.D., Group Medical Director, Neuroscience at Genentech discusses the recent FDA approval of Enspryng™ (satralizumab-mwge) and the fi...